J7612 HCPCS code: Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
J7612 is the HCPCS Level II code for levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg. In 2024 Medicare paid an average of $0.18 per service for J7612 across 1,262 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 900 per day on DME suppliers. Medicare volume rose 110% from 2022 to 2024 (601 to 1,262 services). In 2024, 302 suppliers billed Medicare for J7612 (purchases), serving 305 beneficiaries; Massachusetts, California, Pennsylvania accounted for 43% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | D1G — Drugs administered through DME |
| Added | 2005-01-01 |
| Last action effective | 2009-07-01 |
Who bills J7612 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 302 |
| Referring clinicians | 308 |
| Medicare beneficiaries | 305 |
| States with claims | 17 |
| Share of services in top 3 states (Massachusetts, California, Pennsylvania) | 43% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 299 | 316 |
| 2023 | 309 | 319 |
| 2024 | 302 | 305 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7612, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 601 | 404 | $0.27 | $0.20 |
| 2023 | 1,003 | 519 | $0.23 | $0.17 |
| 2024 | 1,262 | 528 | $0.26 | $0.18 |
States with the most J7612 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 602 | $0.17 |
| New York | 343 | $0.19 |
| Georgia | 32 | $0.15 |
| Louisiana | 31 | $0.18 |
| Texas | 21 | $0.18 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 900 | Clinical: Data |
| practitioner claims | 10 | Prescribing Information |
What changed for J7612
- 2005-01-01: J7612 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7612?
J7612 is the HCPCS Level II code for levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg. Short descriptor: "Levalbuterol non-comp con".
How much does Medicare pay for J7612?
In 2024, the average Medicare payment was $0.18 per service (average allowed $0.26).
Does Medicare cover J7612?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J7612 can be billed per day?
900 on DME suppliers; 10 on practitioner claims (NCCI medically unlikely edits).
Related J76 codes
- J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
- J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
- J7605 — Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
- J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
- J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
- J7608 — Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
- J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7611 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
- J7613 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
- J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
- J7615 — Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7612
- Watch J7612 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7612
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.